| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |